Tokyo Tape
Sign in
← Ensuiko Sugar Refining

Quarterly report · Q2

2112.TEDINET S100S41D
Period2023-04-01 → 2023-09-30
Filed2023-11-02
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥15.6bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥27.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥13.4bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥546m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥274m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.2bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥731m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥244m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥244m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥901m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥498m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥138m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥901m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥138m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥26.2bnat 2023-09-30Cons.Assets
Total assets¥25.9bnat 2023-03-31Cons.Assets
Total assets¥25.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥13.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥14.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥11.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥2.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥1.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥434m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥447m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥104m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥76m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥374m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥172m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥33.012023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.482023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.282022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.12022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.142022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio41.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥67m
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥59m
Otherother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥8m
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥37m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥59m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥59m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥621m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2023-04-01 → 2023-09-30¥964m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2023-04-01 → 2023-09-30¥927m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥37m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2023-04-01 → 2023-09-30¥211m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥13m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2023-04-01 → 2023-09-30¥919m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥59m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥1.2bn
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥67m
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥59m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8m
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥30m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥55m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥55m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥577m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2022-04-01 → 2022-09-30¥925m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2022-04-01 → 2022-09-30¥891m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥34m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2022-04-01 → 2022-09-30¥238m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥13m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2022-04-01 → 2022-09-30¥582m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥55m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥851m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 498
ItemContextValueUnit
Net salesCurrentYTDDuration15566000000JPY
Cost of salesPrior1YTDDuration11630000000JPY
Cost of salesCurrentYTDDuration13500000000JPY
Gross profitPrior1YTDDuration1753000000JPY
Gross profitCurrentYTDDuration2066000000JPY
Selling general and administrative expensesPrior1YTDDuration1479000000JPY
Selling general and administrative expensesCurrentYTDDuration1519000000JPY
Operating incomePrior1YTDDuration274000000JPY
Operating incomeCurrentYTDDuration546000000JPY
Interest income noiPrior1YTDDuration13000000JPY
Interest income noiCurrentYTDDuration17000000JPY
Dividends income noiPrior1YTDDuration67000000JPY
Dividends income noiCurrentYTDDuration718000000JPY
Other noiPrior1YTDDuration25000000JPY
Other noiCurrentYTDDuration14000000JPY
Non operating incomePrior1YTDDuration106000000JPY
Non operating incomeCurrentYTDDuration750000000JPY
Interest expenses noePrior1YTDDuration45000000JPY
Interest expenses noeCurrentYTDDuration49000000JPY
Equity in losses of affiliates noePrior1YTDDuration85000000JPY
Equity in losses of affiliates noeCurrentYTDDuration57000000JPY
Commission fee noePrior1YTDDuration3000000JPY
Commission fee noeCurrentYTDDuration3000000JPY
Other noePrior1YTDDuration0JPY
Other noeCurrentYTDDuration0JPY
Non operating expensesPrior1YTDDuration135000000JPY
Non operating expensesCurrentYTDDuration110000000JPY
Ordinary incomePrior1YTDDuration244000000JPY
Ordinary incomeCurrentYTDDuration1186000000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration1000000JPY
Extraordinary incomePrior1YTDDuration－JPY
Extraordinary incomeCurrentYTDDuration1000000JPY
Income before income taxesPrior1YTDDuration244000000JPY
Income before income taxesCurrentYTDDuration1188000000JPY
Income taxes currentPrior1YTDDuration112000000JPY
Income taxes currentCurrentYTDDuration289000000JPY
Income taxes deferredPrior1YTDDuration-6000000JPY
Income taxes deferredCurrentYTDDuration-3000000JPY
Income taxesPrior1YTDDuration105000000JPY
Income taxesCurrentYTDDuration286000000JPY
Profit lossPrior1YTDDuration138000000JPY
Profit lossCurrentYTDDuration901000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration138000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration901000000JPY
Profit lossPrior1YTDDuration138000000JPY
Profit lossCurrentYTDDuration901000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-17000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration697000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration2000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass